Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2009

01-12-2009 | Research Article

Clinical pharmacy services in an Iranian teaching hospital: a descriptive study

Authors: Simin Dashti-Khavidaki, Hossein Khalili, Hadi Hamishekar, Sheida Shahverdi

Published in: International Journal of Clinical Pharmacy | Issue 6/2009

Login to get access

Abstract

Objective To understand the types of services provided by Iranian clinical pharmacists in nephrology and infectious disease wards, the acceptance rate of clinical pharmacy services in these wards by physicians and the clinical significance of these services in the main teaching hospital in Iran. Setting: Nephrology and infectious disease departments of a university hospital in Iran. Methods During a 12-month prospective data gathering phase, details of all clinical pharmacy services in the nephrology and infectious disease wards of a large university hospital were recorded in the pharmacotherapy monitoring forms. Significance impact of clinical pharmacists’ services was assessed according to the guidelines of The Society of Hospital Pharmacists of Australia. Main outcome measure: Number and type of services provided. Results During 1 year, clinical pharmacists contributed to 1,386 services for 1,105 patients who were admitted in these two wards; of these services, about 95% were accepted by the physicians and about half of them were of moderate-to-life saving clinical significance. Also at least 32% of services were considered to reduce the cost of drug therapy. Conclusions These results support the importance of clinical pharmacists’ participation in health care team rounds to improve the overall quality of medication therapy, enhance patient care and outcome and reduce drug costs to patients and society.
Literature
1.
go back to reference Schumock GT, Butter MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL, et al. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy. 2003;23(1):113–32.CrossRefPubMed Schumock GT, Butter MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL, et al. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy. 2003;23(1):113–32.CrossRefPubMed
2.
go back to reference Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2003;57(4):513–21.CrossRef Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2003;57(4):513–21.CrossRef
3.
go back to reference Clavert RT. Clinical pharmacy—a hospital perspective. Br J Clin Pharmacol. 1999;47(3):231–8.CrossRef Clavert RT. Clinical pharmacy—a hospital perspective. Br J Clin Pharmacol. 1999;47(3):231–8.CrossRef
4.
go back to reference Plumridge RJ, Wojnar-Horton RE. A review of the pharmacoeconomics of pharmaceutical care. Pharmacoeconomics. 1998;14(2):175–89.CrossRefPubMed Plumridge RJ, Wojnar-Horton RE. A review of the pharmacoeconomics of pharmaceutical care. Pharmacoeconomics. 1998;14(2):175–89.CrossRefPubMed
5.
go back to reference George B, Silcock J. Economic evaluation of pharmacy services—fact or fiction? Pharm World Sci. 1999;21(4):147–51.CrossRefPubMed George B, Silcock J. Economic evaluation of pharmacy services—fact or fiction? Pharm World Sci. 1999;21(4):147–51.CrossRefPubMed
6.
go back to reference Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total costs of care in United States hospitals. Pharmacotherapy. 2000;20(6):609–21.CrossRefPubMed Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total costs of care in United States hospitals. Pharmacotherapy. 2000;20(6):609–21.CrossRefPubMed
7.
go back to reference Plam DQ. Evaluating the impact of clinical interventions by Pharm D students on internal medicine clerkships: the results of a 3 year study. Ann Pharmacother. 2006;40:1541–5.CrossRef Plam DQ. Evaluating the impact of clinical interventions by Pharm D students on internal medicine clerkships: the results of a 3 year study. Ann Pharmacother. 2006;40:1541–5.CrossRef
8.
go back to reference Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. An economic analysis of a randomized, controlled, multicentre study on clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Pharmacotherapy. 2000;20(10):1149–58.CrossRefPubMed Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. An economic analysis of a randomized, controlled, multicentre study on clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Pharmacotherapy. 2000;20(10):1149–58.CrossRefPubMed
9.
go back to reference Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):659–700.CrossRef Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):659–700.CrossRef
10.
go back to reference Roberts MS, Stockes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51(3):257–65.CrossRefPubMed Roberts MS, Stockes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51(3):257–65.CrossRefPubMed
11.
go back to reference Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned readmissions and out-of-hospital death. J Am Geriatr Soc. 1998;46(2):174–80.PubMed Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned readmissions and out-of-hospital death. J Am Geriatr Soc. 1998;46(2):174–80.PubMed
12.
go back to reference McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999;159(19):2306–9.CrossRefPubMed McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999;159(19):2306–9.CrossRefPubMed
13.
go back to reference Dooley MJ, Bogovic A, Carroll M, Cuell S, Galbraith K, Matthews H. SHPA standards of practice for clinical pharmacy: SHPA committee of specialty practice in clinical pharmacy. J Pharm Pract Res. 2005;35(2):122–46. Dooley MJ, Bogovic A, Carroll M, Cuell S, Galbraith K, Matthews H. SHPA standards of practice for clinical pharmacy: SHPA committee of specialty practice in clinical pharmacy. J Pharm Pract Res. 2005;35(2):122–46.
14.
go back to reference Charpiat B, Conort O, Rose FX, Escofier L, Juste M, Roubille R, et al. Assessment of clinical pharmacists’ interventions in French hospitals: results of a multicenter study. Ann Pharmacother. 2008;42(7):1095–103.CrossRefPubMed Charpiat B, Conort O, Rose FX, Escofier L, Juste M, Roubille R, et al. Assessment of clinical pharmacists’ interventions in French hospitals: results of a multicenter study. Ann Pharmacother. 2008;42(7):1095–103.CrossRefPubMed
15.
go back to reference Leape LL, Cullen D, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation in physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;281(3):267–70.CrossRef Leape LL, Cullen D, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation in physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;281(3):267–70.CrossRef
16.
go back to reference Bates DW, Leape LL, Cullen DJ, Larid N, Petersen LA, Teich JM. Effects of computerized physician order entry and a team intervention on prevention of serous medication errors. JAMA. 1998;280:1311–6.CrossRefPubMed Bates DW, Leape LL, Cullen DJ, Larid N, Petersen LA, Teich JM. Effects of computerized physician order entry and a team intervention on prevention of serous medication errors. JAMA. 1998;280:1311–6.CrossRefPubMed
17.
go back to reference Dale A, Copeland R, Barton R. Prescribing errors on medical wards and the impact of clinical pharmacists. Int J Pharm Pract. 2003;11:19–24.CrossRef Dale A, Copeland R, Barton R. Prescribing errors on medical wards and the impact of clinical pharmacists. Int J Pharm Pract. 2003;11:19–24.CrossRef
18.
go back to reference Bosma L, Jansman FGA, Franken AM, Harting JW, Van Den Bemt PMLA. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci. 2008;30(1):31–8.CrossRefPubMed Bosma L, Jansman FGA, Franken AM, Harting JW, Van Den Bemt PMLA. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci. 2008;30(1):31–8.CrossRefPubMed
19.
go back to reference Brown C. Physicians acceptance of drug-therapy recommendations using a written data and communications form. Consult Pharm. 1991;6:729–34. Brown C. Physicians acceptance of drug-therapy recommendations using a written data and communications form. Consult Pharm. 1991;6:729–34.
Metadata
Title
Clinical pharmacy services in an Iranian teaching hospital: a descriptive study
Authors
Simin Dashti-Khavidaki
Hossein Khalili
Hadi Hamishekar
Sheida Shahverdi
Publication date
01-12-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9336-6

Other articles of this Issue 6/2009

International Journal of Clinical Pharmacy 6/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.